A cultured mouse myeloma cell line, S107, that secretes an IgA phosphocholine-binding immunoglobulin has been cloned in soft agar and overlaid with phosphocholinehemocyanin. Spontaneous mutants that secrete immunoglobulin with a decreased ability to precipitate antigen were detected with this plate assay and occur at a very high frequency. From one such mutant, phenotypic revertants arise spontaneously with a frequency of 0.28-2.8%. This mutant and one of its revertants were studied, and they were found to differ from the parent and from each other serologically and in antigen binding. While it is not yet clear whether these findings bear any relationship to the normal generation of antibody diversity, they do indicate that it is possible to generate antigen binding diversity in somatic cells.
with a frequency of 0.28-2.8%. This mutant and one of its revertants were studied, and they were found to differ from the parent and from each other serologically and in antigen binding. While it is not yet clear whether these findings bear any relationship to the normal generation of antibody diversity, they do indicate that it is possible to generate antigen binding diversity in somatic cells.
In recent years, biologists have devoted considerable thought and effort to trying to understand how individuals produce the large number of antibodies that they require to respond to a seemingly limitless number of different antigens (1) . Chemical studies of naturally occurring antibodies and myeloma proteins have shown that the recognition of many different antigens depends on the generation of an enormous amino acid sequence diversity in small areas of the NH2-terminal part of immunoglobulin polypeptide chains (2-4). In the heavy (H) chain, these areas, called the hypervariable regions, are found between residues 31 and 35, 50 and 65, and 95 and 107 (4) . The evidence that these hypervariable regions form the antigen-binding site comes from correlations between sequence and specificity (4), affinity labeling with antigens (5) , and studies on the threedimensional structure of antibodies (6, 7) . There has been a great deal of discussion about whether the generation of this sequence diversity occurred during evolution, with genes for each of these many sequences being inherited through the germ line, or if diversity is generated somatically through the mutation of a limited number of germ line genes (1) .
A few investigators have tried to demonstrate a somatic generation of antibody diversity by looking for structural gene mutations in cultured immunoglobulin-producing cells. In fact, in cultured mouse myeloma cells, the production of immunoglobulins is very unstable (8, 9) . Spontaneous variants arise at a rate of 10-3/cell per generation, and certain mutagens increase the frequency of variants to as high as 2-6% of surviving clones (10, 11) . While many of these spontaneous and mutagen-induced variants have lost the ability to produce immunoglobulin, approximately 40% of the mutagen-induced variants do produce heavy chains that differ structurally from the parental heavy chains (12, 13) . Milstein and his colleagues have used amino acid and nucleic acid sequence studies to show that frameshift, missense, and nonsense mutations occur spontaneously in their cultured cell lines (8) . The genetic instability of immunoglobulin production is not due to a general instability
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in mouse myeloma cells because mutants resistant to 6-thioguanine and bromodeoxyuridine arise in the same cells at a rate of 10-6-10-7/cell per generation (10) . Although this enormous genetic instability in cultured myeloma cells might have suggested a somatic generation of antibody diversity, all of the mutations reported so far (8, 12, 13) Between 250 and 1000 clones were scored per plate. Subclones and presumptive variants were removed from the agarose and grown up to mass culture as described previously (17) .
Labeling of Cells and Electrophoretic and Chromatographic Analysis of Labeled Protein. Logarithmically growing cells were incubated with '4C-or 3H-labeled valine, threonine, and leucine, and the intracellular or secreted immunoglobulins were specifically precipitated and analyzed on acrylamide gels containing sodium dodecyl sulfate. For the analysis of the tryptic-chymotryptic peptides, secreted immunoglobulins were completely reduced and alkylated, heavy and light chains were purified on cylindrical sodium dodecyl sulfate gels, and the digests were prepared and analyzed by ion exchange chromatography using pyridine acetate buffer. The details of these techniques have been described previously (19, 20) .
Purification of Wild-Type and Mutant Proteins. Wild-type, mutant, or revertant cells were injected intraperitoneally into pristane-primed BALB/c mice (21) . The ascites fluid was collected and the immunoglobulin was purified by affinity chromatography on a PC-Tyr-Gly-Sepharose 4B column followed by elution with PC and dialysis (22) . The purity of each protein preparation was confirmed using both sodium dodecyl sulfate/acrylamide gels to examine the size of the protein and nondissociating Tris/glycine gels (23) to analyze the charge homogeneity of the preparation. No contaminating proteins were detected.
Radioimmunoassay with Anti-variable Region Antisera and with PC-KLH. Rabbits were immunized with purified S107 and early high titer bleedings were used to prepare two types of antibody specific for the S107 variable region. Antiserum reactive with the PC-binding site was prepared as described by Claflin and Davie (24) . Briefly, the S107 protein was coupled to Sepharose 4B and the rabbit antibody raised against the S107 protein was passed through the column. After thorough washing, those antibodies that were bound to the PCbinding site were eluted with a large excess of PC. The hapten was then removed by extensive dialysis (24) . Antiserum specific for the S107 variable region was prepared by successive absorptions with Sepharose 4B coupled with: (i) W3129 protein, an al,6-dextran-binding IgA K (kindly provided by Sherie Morrison); (ii) normal mouse serum; and (iii) a mixture of protein from the MOPC 511 and McPC 603 tumors, both of which produce IgA KS that bind PC but differ from S107 in their idiotype and light chains (25) . The absorbed antiserum reacts in double diffusion in agar (Ouchterlony) with S107 protein and with protein from the HOPC-8 tumor, an IgA K myeloma that binds PC and has the same variable region serology as S107, but does not react with other IgA or IgG myelomas.
Radioactive S107 protein was endogenously labeled by incubating cells with [-5S]methionine and purifying the secreted protein with PC-Sepharose (22) . Radioimmunoassays were performed using an adaptation of a solid-phase assay employing polyvinyl microtiter plates (26) . Amounts of antiserum or PC-KLH sufficient to bind 4000 cpm of the 35S-labeled S107 protein were used to coat each well. A number of clones that did not react with PC-KLH in the plate assay were recovered, grown to mass culture, and characterized in more detail. For example, in one experiment, ten unstained clones were recovered. Three no longer synthesized IgA heavy chains. The remaining seven all synthesized and secreted IgA. Both the intracellular and secreted IgA of the parental clone precipitated with PC-KLH in agar diffusion (Ouchterlony). The intracellular and secreted material of the seven unstained clones did not react with PC-KLH under identical conditions. The secreted material from all seven unstained clones was shown to retain some PC-binding activity by the more sensitive hemagglutination assay. This preliminary analysis confirmed that most of the variant clones did secrete IgA but that the IgA differed from the parent in its ability to bind PC. This was not due to differences in the amount of immunoglobulin secreted because medium from mutants and the parent contained similar amounts of IgA as assayed by radial immunodiffusion. IgA-positive PC-KLH-negative variants from three independent experiments were recloned and then the cells were incubated with radioactive amino acids and their intracellular and secreted immunoglobulins were analyzed on polyacrylamide gels containing sodium dodecyl sulfate. All but one synthesized heavy and light chains that comigrated with those of the parent and assembled their chains into higher polymers similar to those produced by the parent (data not shown).
One of the variants, SIU9, synthesized a heavy chain that spurred with the parent when reacted with anti-IgA on Ouchterlony analysis, indicating that it had lost some antigenic determinants. Gel electrophoresis of the IgA secreted by this variant revealed that the heavy chain was smaller than that of the parent and was disulfide linked to the light chain, forming an HL half molecule. Similar defective IgAs are produced by mouse myelomas that synthesize IgA heavy chains with a COOH-terminal deletion; such IgAs lack inter-heavy chain disulfide bonds and form abnormal disulfide bonds between their heavy and light chains to produce HL half molecules (21, 29, 30) . We assume that this mutant has a related defect, although it has not yet been studied further. The apparent change in antigen binding in SIU9 could be due to the fact that it is (Fig. 1) . Arrows indicate differences. monovalent for PC and therefore could not form the lattice necessary to produce a visible antigen-antibody precipitate.
One mutant (Ul) was studied in more detail. Its endogenously labeled heavy and light chains were purified and digested with trypsin and chymotrypsin, and the resulting peptides were compared with those of the parent. The mutant and parental light chains appear identical (Fig. 1) . The heavy chains are also largely similar but there are a few differences (Fig. 2) , which were seen in two independent analyses.
The mutant cells were recloned and injected into the peritoneal cavity of pristane-primed mice. The mutant protein was purified from the resultant ascites fluid and its ability to bind to PC was compared with that of the parent. With a radioimmunossay, it can be seen that the mutant binds to PC but that approximately a 10-fold excess of mutant protein is required to compete with the parental protein for 50% of the hapten sites (Fig. 3) .
Antibody specific for the S107 variable region was prepared as described in Materials and Methods. When this antibody was used in a solid-phase radioimmunoassy, the mutant U1 was indistinguishable from the parent (Fig. 4A) . However, when PC-binding-site-specific antibody was used, the mutant was significantly less reactive than the parent (Fig. 4B) . MOPC 511 protein, which binds PC, but has a different variable region serology from S107, was included as a control for these two assays.
These chemical, antigen-binding, and serological studies all suggest that the mutant has undergone a small change in its 100! (Fig. 3 ). When examined with either specific (Fig. 4A) 
